DNA and RNA vaccines represent groundbreaking advancements in vaccination technology. Unlike traditional vaccines that use weakened or inactivated viruses, DNA and RNA vaccines work by introducing genetic material (DNA or RNA) from the pathogen into the body. Once inside, the body's cells use this genetic material to produce a harmless part of the virus, triggering an immune response. These vaccines are highly adaptable, allowing for rapid development to combat emerging diseases like COVID-19. DNA vaccines deliver a small, circular DNA strand, while RNA vaccines use messenger RNA to instruct cells to create viral proteins. Both types are safe, efficient, and offer promising avenues for combating infectious diseases while potentially revolutionizing future vaccine development.
Important Alert:
X
Title : Optimizing vaccine trial design: A novel promising zone approach with adaptive Interim analysis for managing delayed effects
Depeng Jiang, University of Manitoba, Canada
Title : Why Antimicrobial Resistance is a Global Threat and Its Impact On Everyone
Regina Au, BioMarketing Insight, United States
Title : Distinct patterns of SARS-CoV-2 genetic variations
Jun Wan, Indiana University School of Medicine, United States
Title : The power of cultural validation when empowering community immunity
Julissa Soto, Julissa Soto Latino Health Equity Consulting, United States
Title : High dilution of Covid-19 positive throat swab shows prophylactic effect and its spectroscopic Studies
Anirban Sukul, Sukul Institute of Homeopathic Research, India
Title : Human challenge clinical trial of vaccines for infectious diseases – A necessary evil
Sudhakar Bangera, AILEEN Clinical Research Services, India
Title : Evaluating community-based vaccine initiatives with power BI
Carly Contri, American Academy of Pediatrics, United States
Title : Novel regulatory mechanisms of innate immunity and inflammation
Ping Xie, Rutgers University, United States
Title : Perception of HPV Vaccination among healthcare professionals in Morocco: Barriers and strategies for improving public acceptance
Filali Houda, Hassan 2 university, Morocco
Title : High prevalence of zero-dose children in underserved and special setting populations in ethiopia using a generalize estimating equation and concentration index analysis
Gashaw Andargie Biks, Project HOPE, Ethiopia